Our Stories

Reset filter
Teva scientist interacting with a large green abstract network graphic illustrating biological pathways and potential pathways for business growth.

Sustaining Teva’s Generics Powerhouse in the Acceleration Phase
Research, development, medicine

Shaping the Future of Medicine through Innovation & Collaboration
Chris Fox, EVP of US Commercial at Teva, and Eric Hughes, MD, PhD, Teva’s EVP of Global R&D and Chief Medical Officer

Innovation and Access: How Teva Is Developing the Next Generation of Medicine

What are Biologics and Biosimilars?
Teva Employees in Israel Research Laboratory

"What Took Us Years Could Now Take Half the Time": Innovation Is Redefining Pharma

‘Our goal is to lead the field of biosimilars, just like we lead in generic medicines’

‘Biosimilars are advancing more treatment options for patients’